loadpatents
name:-0.039547920227051
name:-0.010971069335938
name:-0.002202033996582
CHADA; Sunil Patent Filings

CHADA; Sunil

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHADA; Sunil.The latest application filed is for "methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer".

Company Profile
2.11.30
  • CHADA; Sunil - Houston TX
  • Chada; Sunil - Missouri City TX
  • Chada; Sunil - Missouri TX
  • Chada, Sunil - Vista CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions Comprising Enhanced Targeted Immune Gene Therapy For The Treatment Of Cancer
App 20220226402 - SETH; Prem ;   et al.
2022-07-21
Methods And Compositions Comprising Tumor Suppressor Gene Therapy And Cd122/cd132 Agonists For The Treatment Of Cancer
App 20210094991 - SOBOL; Robert E. ;   et al.
2021-04-01
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising The Vectors, And Uses Thereof
App 20200239906 - Roeth; Jeremiah F. ;   et al.
2020-07-30
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
Grant 10,584,351 - Roeth , et al.
2020-03-10
Methods And Compositions Comprising Viral Gene Therapy And An Immune Checkpoint Inhibitor For Treatment And Prevention Of Cancer
App 20200009203 - SOBOL; Robert E. ;   et al.
2020-01-09
Compositions Comprising Tumor Suppressor Gene Therapy And Immune Checkpoint Blockade For The Treatment Of Cancer
App 20190038713 - SOBOL; Robert E. ;   et al.
2019-02-07
Vectors Conditionally Expressing Protein
App 20180344876 - ROETH; Jeremiah F. ;   et al.
2018-12-06
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
App 20180002719 - ROETH; Jeremiah F. ;   et al.
2018-01-04
Vectors Conditionally Expressing Protein
App 20160317678 - ROETH; Jeremiah F. ;   et al.
2016-11-03
Vectors conditionally expressing protein
Grant 9,402,919 - Roeth , et al. August 2, 2
2016-08-02
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
App 20160208285 - Roeth; Jeremiah F. ;   et al.
2016-07-21
P53 Vaccines For The Treatment Of Cancers
App 20150044240 - Antonia; Scott ;   et al.
2015-02-12
Vectors Conditionally Expressing Protein
App 20140308247 - Roeth; Jeremiah F. ;   et al.
2014-10-16
P53 vaccines for the treatment of cancers
Grant 8,668,905 - Antonia , et al. March 11, 2
2014-03-11
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
App 20130195800 - Roeth; Jeremiah F. ;   et al.
2013-08-01
Use of MDA-7 to inhibit pathogenic infectious organisms
Grant 8,034,790 - Chada October 11, 2
2011-10-11
Oncolytic Adenovirus Armed with Therapeutic Genes
App 20080292592 - Chada; Sunil ;   et al.
2008-11-27
Antihelminthic drugs as a treatment for hyperproliferative diseases
Grant 7,423,015 - Mukhopadhyay , et al. September 9, 2
2008-09-09
Compositions and Methods Involving MDA-7 for the Treatment of Cancer
App 20070281041 - Ramesh; Rajagopal ;   et al.
2007-12-06
Prognostic Factors For Anti-hyperproliferative Disease Gene Therapy
App 20070231304 - Sobol; Robert E. ;   et al.
2007-10-04
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
App 20070066552 - Clarke; Peter ;   et al.
2007-03-22
P53 vaccines for the treatment of cancers
App 20070003550 - Antonia; Scott ;   et al.
2007-01-04
Methods and compositions involving MDA-7
App 20060134801 - Chada; Sunil ;   et al.
2006-06-22
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
App 20060063697 - Gabrilovich; Dmitry ;   et al.
2006-03-23
Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
App 20060052322 - Roth; Jack A. ;   et al.
2006-03-09
Use of MDA-7 to inhibit pathogenic infectious organisms
App 20050233959 - Chada, Sunil
2005-10-20
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
App 20050171045 - Gabrilovich, Dmitry ;   et al.
2005-08-04
Methods of enhancing immune induction involving MDA-7
App 20040009939 - Chada, Sunil ;   et al.
2004-01-15
Adenoviral p53 gene transfer in the prevention and treatment of injury-induced vascular smooth muscle cell proliferation
App 20030223967 - Zumstein, Louis ;   et al.
2003-12-04
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
App 20030045499 - Gabrilovich, Dmitry ;   et al.
2003-03-06
Methods of treatment involving human MDA-7
App 20020183271 - Chada, Sunil ;   et al.
2002-12-05
Immunostimulation mediated by gene-modified dendritic cells
App 20020123479 - Song, Elizabeth S. ;   et al.
2002-09-05
Non-immunogenic Prodrugs And Selectable Markers For Use In Gene Therapy
App 20020082224 - JOLLY, DOUGLAS J. ;   et al.
2002-06-27
Crossless retroviral vectors
Grant 6,333,195 - Respess , et al. December 25, 2
2001-12-25
Crossless retroviral vectors
Grant 6,013,517 - Respess , et al. January 11, 2
2000-01-11
Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
Grant 5,736,388 - Chada , et al. April 7, 1
1998-04-07
Anti-cancer immunotherapeutics
Grant 5,693,522 - Chada , et al. December 2, 1
1997-12-02
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed